What you will learn
- How to develop and manage FDA-compliant pharmaceutical SEO and SEM efforts
- What Google should do to facilitate a better patient search experience
- How to use rich media to maximize digital pharmaceutical campaigns
An Eye on Google
Re-Engaging with Digital Marketing in Response to Recent FDA Warnings
Overview
Recent warnings by the FDA and long-standing concerns regarding digital pharmaceutical advertising have made it increasingly difficult to safely develop interactive campaigns. RTCRM believes that success will not come by deciding whether or not to do paid search or banner ads, but rather in the creative and experiential execution of all digital strategies.
This white paper presents a wide-ranging investigation into digital best practices, potential regulatory pitfalls and emerging strategies for pharmaceutical marketing on the Web.
Key topics include: current FDA requirements affecting paid search and banner advertising; the role of Google as the dominant player in search engine marketing; the relative merits (and challenges) of branded vs. unbranded campaigns; creative best practices that maximize ROI; and more.